Fouad Namouni

Insider Reports History

Entity
Individual
Location
535 Boylston St., 2 Nd Floor, Boston, Massachusetts
Signature
/s/ Katie Kazem, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fouad Namouni:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp PRESIDENT, R & D Common Stock 72.7K $6.59M $90.69 Mar 7, 2024 Direct
Aprea Therapeutics, Inc. Director Common Stock 4.61K $17K $3.68 Jun 30, 2021 Direct
Blueprint Medicines Corp PRESIDENT, R & D Stock Option (Right to Buy) 30K Mar 1, 2024 Direct
Vor Biopharma Inc. Director Stock Option (Right to Buy) 30K May 23, 2024 Direct
Aprea Therapeutics, Inc. Director Stock Option (Right to Buy) 22.8K Jun 30, 2021 Direct

Insider Reports Filed by Fouad Namouni

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VOR Vor Biopharma Inc. May 23, 2024 1 $0 4 May 28, 2024 Director
VOR Vor Biopharma Inc. Apr 30, 2024 1 $0 4 May 2, 2024 Director
VOR Vor Biopharma Inc. Apr 30, 2024 0 $0 3 May 2, 2024 Director
BPMC Blueprint Medicines Corp Mar 7, 2024 1 -$397K 4 Mar 11, 2024 PRESIDENT, R & D
BPMC Blueprint Medicines Corp Mar 1, 2024 2 $0 4 Mar 6, 2024 PRESIDENT, R & D
BPMC Blueprint Medicines Corp Oct 4, 2023 1 -$181K 4 Oct 5, 2023 PRESIDENT, R & D
BPMC Blueprint Medicines Corp Mar 6, 2023 2 -$89K 4 Mar 8, 2023 PRESIDENT, R & D
BPMC Blueprint Medicines Corp Mar 1, 2023 2 $0 4 Mar 3, 2023 PRESIDENT, R & D
BPMC Blueprint Medicines Corp Oct 4, 2022 1 -$234K 4 Oct 5, 2022 PRESIDENT, R & D
BPMC Blueprint Medicines Corp Mar 7, 2022 1 -$58.8K 4 Mar 8, 2022 PRESIDENT, R & D
BPMC Blueprint Medicines Corp Mar 1, 2022 2 $0 4 Mar 3, 2022 PRESIDENT, R & D
BPMC Blueprint Medicines Corp Oct 5, 2021 1 -$318K 4 Oct 7, 2021 President, R & D
APRE Aprea Therapeutics, Inc. Jun 30, 2021 2 $0 4 Jul 1, 2021 Director